Exploring Apathy After Minor Stroke and Transient Ischemic Attack
Non-disabling Ischemic Cerebrovascular Event With Apathy: A Prospective Registry Trail
This study looks at how feeling apathetic after a minor stroke or TIA affects recovery and the chances of having another stroke in adults during their first year after the event.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Changhai Hospital Academic / other |
| Locations | 1 site (Shanghai, Shanghai) |
| Trial ID | NCT04917237 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the relationship between baseline apathy and the likelihood of subsequent strokes in adults who have experienced transient ischemic attacks (TIA) or minor strokes. It aims to establish the prevalence and predictors of post-stroke apathy (PSA) in these patients during the first year following their initial event. By focusing on this often-overlooked aspect of recovery, the study seeks to enhance understanding of how apathy affects functional recovery and quality of life in stroke survivors.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have recently experienced a minor stroke or transient ischemic attack.
Not a fit: Patients with severe comorbid conditions, such as malignant tumors or severe liver or kidney disease, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved recognition and management of apathy in stroke patients, potentially enhancing their recovery and quality of life.
How similar studies have performed: Previous studies have indicated that post-stroke apathy is a significant issue affecting recovery, suggesting that this study's focus on TIA and minor stroke patients is both relevant and necessary.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: ≥18 years old Onset of a minor stroke (National Institute of Health stroke scale, NIHSS≤3) and TIA elapsed time from last episode to registry \<1 month Exclusion Criteria: patients who refused to participate in the research, and patients who failed to complete the follow-up protocol. patients with malignant tumors, or patients with severe liver or kidney disease, whose life expectancy is less than 1 year. patients who received endovascular or thrombolytic therapy.
Where this trial is running
Shanghai, Shanghai
- Changhai Hospital — Shanghai, Shanghai, China (Recruiting)
Study contacts
- Principal investigator: Xiaoying Bi, MD, PhD — Department of Changhai Hospital
- Study coordinator: Xiaoying Bi, MD, PhD
- Email: bixiaoying2013@163.com
- Phone: 86-13795274796
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.